Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours.

MLA

Boller, Danielle, et al. “Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours.” Anticancer Research, vol. 32, no. 8, Aug. 2012, pp. 3015–27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=22843869&authtype=sso&custid=ns315887.

APA

Boller, D., Doepfner, K. T., De Laurentiis, A., Guerreiro, A. S., Marinov, M., Shalaby, T., Depledge, P., Robson, A., Saghir, N., Hayakawa, M., Kaizawa, H., Koizumi, T., Ohishi, T., Fattet, S., Delattre, O., Schweri-Olac, A., Höland, K., Grotzer, M. A., Frei, K., … Arcaro, A. (2012). Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours. Anticancer Research, 32(8), 3015–3027.

Chicago

Boller, Danielle, Kathrin T Doepfner, Angela De Laurentiis, Ana S Guerreiro, Marin Marinov, Tarek Shalaby, Paul Depledge, et al. 2012. “Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours.” Anticancer Research 32 (8): 3015–27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=22843869&authtype=sso&custid=ns315887.